Waters Corporation to Present at TD Cowen Health Care Conference
Waters Corporation, a prominent player in the life sciences arena, will have its President and CEO, Udit Batra, Ph.D., participate in a significant event—the TD Cowen Health Care Conference. Scheduled for
March 2, 2026, at
11:10 AM Eastern Time, this fireside chat promises to deliver valuable insights into the company’s ongoing initiatives and future direction.
Event Details
The conference will feature a live webcast available on the Waters Investor Relations website, where investors and interested parties can tune in to hear directly from Dr. Batra. Post-event, a replay will be accessible for
90 days, ensuring a broader audience can glean insights from the discussion. Attending these conferences is pivotal as they allow companies like Waters to communicate vital updates and interact with stakeholders, enhancing transparency and investment appeal.
About Waters Corporation
Founded with a commitment to advancing science, Waters Corporation (NYSE: WAT) specializes in providing analytical technologies and services that encourage breakthroughs in health and safety. Their focus spans across crucial areas such as:
- - Pharmaceutical Development: Waters helps in bringing effective and high-quality medicines to market by streamlining the testing processes for drug development.
- - Food and Water Safety: By utilizing their analytical tools, they support the safety and quality of food and water, contributing to public health standards worldwide.
- - Disease Management: Waters continues to advance methods that help detect diseases earlier and manage routine infections, playing a crucial role in combating antibiotic resistance.
The company prides itself on its innovative portfolio, underpinned by deep scientific expertise in chemistry, biology, and physics. With about
16,000 professionals on board, Waters works tirelessly under a culture of relentless innovation, addressing scientific challenges and transforming them into real-world solutions that enhance lives globally.
Looking Ahead
As the TD Cowen Health Care Conference approaches, industry watchers and investors are eager to learn about Waters Corporation’s latest research activities, market strategies, and how they plan to maintain their leadership in the life sciences and diagnostics space. With an emphasis on regulatory compliance and high-volume testing environments, the discussions are expected to highlight Waters' ongoing commitment to excellence and innovation.
For individuals keen to stay updated, visiting the
Waters Investor Relations page will allow easy access to live events, past presentations, and company news, reinforcing their dedication to investor education and engagement. As the life sciences industry evolves, Waters remains at the forefront, committed to ensuring that science delivers impactful and reliable solutions.
By participating in this conference, Waters Corporation not only showcases its initiatives but also underlines the importance of collaboration in scientific fields, poised to address global health challenges effectively.